These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6470552)

  • 1. [Effects of the "drug holiday" on problems of long-term levodopa therapy against Parkinson's disease].
    Mizuno Y; Joshita Y; Yoshida M; Kaneko J; Tanaka Y; Nagatsuka Y
    Nihon Naika Gakkai Zasshi; 1984 Apr; 73(4):474-80. PubMed ID: 6470552
    [No Abstract]   [Full Text] [Related]  

  • 2. Reappraisal of temporary levodopa withdrawal ("drug holiday") in Parkinson's disease.
    Mayeux R; Stern Y; Mulvey K; Cote L
    N Engl J Med; 1985 Sep; 313(12):724-8. PubMed ID: 4033697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Drug holidays' in the treatment of Parkinson's disease. A brief review.
    Friedman JH
    Arch Intern Med; 1985 May; 145(5):913-5. PubMed ID: 3888135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The results of drug holiday in Parkinson's disease].
    Martínez F; Castillo J; Castro A; Lema M; Noya M
    Neurologia; 1992 Nov; 7(9):254-9. PubMed ID: 1445710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on long-term levodopa therapy in Parkinson's disease].
    Mizuno Y
    Nihon Naika Gakkai Zasshi; 1982 Nov; 71(11):1553-9. PubMed ID: 7166671
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-acting carbidopa-levodopa in the management of moderate and advanced Parkinson's disease.
    Hutton JT; Morris JL
    Neurology; 1992 Jan; 42(1 Suppl 1):51-6; discussion 57-60. PubMed ID: 1549202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
    Koziorowski D; Friedman A
    Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI; Mark MH
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response to levodopa in Parkinson's disease: imposing pharmacological law and order.
    Nutt JG; Holford NH
    Ann Neurol; 1996 May; 39(5):561-73. PubMed ID: 8619540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An analysis of long-term L-dopa treatment on 122 cases of Parkinson's disease over 14 years--when should L-dopa therapy be initiated?].
    Indo T; Takahashi A
    Rinsho Shinkeigaku; 1986 Apr; 26(4):363-71. PubMed ID: 3731637
    [No Abstract]   [Full Text] [Related]  

  • 11. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
    Teychenne PF; Bergsrud D; Elton RL; Racy A
    Clin Neuropharmacol; 1986; 9(2):138-45. PubMed ID: 3708599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Drug holiday" in Parkinson's disease.
    Kenny A; Murrin LC; Pfeiffer RF
    Nebr Med J; 1987 May; 72(5):149-53. PubMed ID: 3587443
    [No Abstract]   [Full Text] [Related]  

  • 13. [Usefulness of increasing the proportion of carbidopa to levodopa in the long-term treatment of Parkinson's disease].
    Bermejo Pareja F; Martínez-Martín P
    Med Clin (Barc); 1984 Feb; 82(7):305-10. PubMed ID: 6717135
    [No Abstract]   [Full Text] [Related]  

  • 14. [Usefulness of drug holiday in patients with Parkinson's disease of more than 5 years of development].
    Corona T; Rivera Nava C; Reyes Báez B; Carbajal A
    Rev Invest Clin; 1991; 43(4):334-7. PubMed ID: 1798867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease.
    Mouradian MM; Heuser IJ; Baronti F; Chase TN
    Ann Neurol; 1990 Jan; 27(1):18-23. PubMed ID: 2301923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multivariate analysis of the problems of long-term levodopa therapy in Parkinson's disease].
    Nakamura Y; Yoshinaga J; Endo S; Hikiji A
    Rinsho Shinkeigaku; 1997 Jun; 37(6):469-75. PubMed ID: 9366172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa-related motor complications--phenomenology.
    Fox SH; Lang AE
    Mov Disord; 2008; 23 Suppl 3():S509-14. PubMed ID: 18781677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease.
    Zappia M; Montesanti R; Colao R; Branca D; Nicoletti G; Aguglia U; Quattrone A
    Mov Disord; 1997 Jan; 12(1):103-6. PubMed ID: 8990062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of motor fluctuations in Parkinson's disease.
    Poewe WH
    Neurology; 1994 Jul; 44(7 Suppl 6):S6-9. PubMed ID: 8047260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I.
    Fabbrini G; Mouradian MM; Juncos JL; Schlegel J; Mohr E; Chase TN
    Ann Neurol; 1988 Sep; 24(3):366-71. PubMed ID: 3228270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.